Greg Renza (RBC Capital Markets)

Focus Areas4 topics

Innovation & R&D1Competitive Dynamics1Geographic Expansion1Revenue Growth1

Trends2 quarters

Questions per Quarter

Companies Covered

Question History2 questions

AMGNAmgen Inc.2 quarters

2025 Q1

Just curious if you could just elaborate how confident you are on the potential for 410 be best or even better in class as you learn more about this molecule.

Innovation & R&DCompetitive DynamicsView in transcript →

2024 Q4

I'm just wondering if you could comment a bit about the opportunity in China and namely, just about the commercial opportunity for those oncology medicines

Geographic ExpansionRevenue GrowthView in transcript →